Fibromyalgia Global Clinical Trials Review, H2, 2017

2017-08-23
Price :
Published : Aug-2017
No. of Pages : 224

Fibromyalgia Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Fibromyalgia Global Clinical Trials Review, H2, 2017” provides an overview of Fibromyalgia clinical trials scenario. This report provides top line data relating to the clinical trials on Fibromyalgia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Debiopharm International SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and in-licenses promising drug candidates for development. Debiopharm's products includes decapeptyl, eloxatin, pamorelin, trelstar, moapar and salvacyl among others. The company offer products for the treatment of in vitro fertilization, metastatic colorectal cancer, advanced prostate cancer, precocious puberty, endometriosis, liver cancer, pancreatic cancer, uterine fibroids, severe sexual deviations and other diseases. It also develops drugs for indications in the therapeutic areas of infectious diseases and orphan drugs. The company provides l......
$250

MicuRx Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. Its lead product candidate includes MRX-I, an oxazolidinone antibiotic, which is intended for the treatment of methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci infections. MicuRx also develops preclinical candidates for gram-positive and gram-negative bacterial infections. It operates through its offices in the US and China. MicuRx is headquartered in Hayward, California, the US. MicuRx Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provid......
$250

NanoBio Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary NanoBio Corp (NanoBio) is a biopharmaceutical company that develops vaccines. The company develops and commercializes intranasal and intramuscular vaccines for the prevention and treatment of infectious diseases. The company's vaccines include anthrax, H5 influenza, pertussis, RSV, HIV, HSV-2, and seasonal influenza. It carries out research and development operations for the development of drugs and vaccines for dermatological conditions, infectious disease and other therapeutic indications. NanoBio also develops products based on proprietary NanoStat development platform that facilitates the development of topical anti-infective products and an array of mucosal vaccines. The company operates through its laboratory located in Michigan. NanoBio is headquartered in Ann Arbor, Mich......
$250

Finnish Funding Agency for Innovation – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Finnish Funding Agency for Innovation (Tekes) is a financing organization that offers research and technological development programs. The organization offers financial services for research, development and novelty. It provides finance for research and development of new technologies, business concepts, networking and management practices. Tekes provides funding services for corporations, universities, research institutions, and government organizations, local and regional authorities. The organization concentrates on research and development collaboration in the areas of information and telecommunication technologies; biotechnology and healthcare systems; and nanotechnology, among others. The organization helps companies to enhance their networking and development potential. I......
$250

Domainex Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Domainex Ltd (Domainex) is a biotechnology company that provides drug discovery technologies and services. The company offers drug discovery services in the areas of medicinal chemistry, computational chemistry, protein expression and purification, biochemical assay development, DMPK analysis, cell biology, combinatorial domain hunting, and hit identification using virtual or fragment-based approaches. It provides methyltransferases and solutions for the treatment of novel treatment for inflammatory diseases such as DMXD-011, a small-molecule orally-bio available inhibitor for rheumatoid arthritis and lupus. Domainex develops a range of drug target classes which include kinases, proteases, ion channels, proteins involved in epigenetics and protein-protein interactions. The compa......
$250

MPI Research Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary MPI Research Inc (MPI) is a contract research company that provides preclinical and early clinical research services. The company's services comprise drug safety services, discovery sciences solutions, bioanalytical and analytical solutions, surgical services, medical device evaluation, translational imaging center services, and general, infusion, developmental, and reproductive toxicology services. Its other services include safety pharmacology, neurobehavioral sciences solutions, anatomic and clinical pathology, drug metabolism and pharmacokinetics, preclinical and clinical bioanalytical analyses, ligand binding assays, monclinical dose formulation and analysis services. MPI also provides surgical efficacy, targeted delivery, medical device evaluation, in vitro services, molec......
$250

National Institute on Drug Abuse – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine, prescription drugs, commonly abused drugs, emerging trends, salvia, and tobacco addiction, among others. It also offers services in addiction science, drug testing, drugged driving, global health, hepatitis, comorbidity, criminal justice and drug abuse areas. The institute operates AIDS research program, international program, and intramural research program, among others. NIDA is headquartered in Bethesda, Maryland, the US. National Institute on Drug Abuse - Pharmaceuticals & Healthcare......
$250

Unchained Labs – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Unchained Labs is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparation system), freeslate and freeslate jr (automated workflow solution). Unchained Labs optim technology platform is developed for various applications such as stability studies, lead candidate selection and optimization, pre-formulation studies, candidate formulation among others. It markets its products to biopharmaceutical companies and academic institutions internationally throughout the world. The company's venture capital is backed by investment firms such as Canaan Partners, TPG biotech, Novo Venture......
$250

Princeton University – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Princeton University (Princeton) is a research university that provides undergraduate and graduate instruction. The university offer education in the areas of humanities, social sciences, natural sciences and engineering. It provides services such as health services, event planning, external affairs, information technology, safety and preparedness, transportation and parking, business systems, finance and purchasing, and legal policies. Princeton operates with academic departments and centers. It offers interdisciplinary undergraduate certificate programs. The university also offers scholarship and master's degree programs in architecture, engineering, finance, and public affairs, among others. Princeton is headquartered in Princeton, New Jersey, the US. Princeton University ......
$250

Kodiak Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Kodiak Sciences Inc (Kodiak Sciences), formerly Oligasis LLC, is a drug company that discovers and develops new medicines for the healthcare sector. The company provides retinal medicines for treatment of wet and dry forms of age-related macular degeneration. It utilizes its proprietary Bioconjugate technology which is a proprietary product platform that combines biologics design with next generation phosphorylcholine Biopolymers. The company also provides multi mechanism, multi format and disease centric medicines. It commercializes its technology to both biopharmaceuticals and small molecules companies. Kodiak Sciences is headquartered in Palo Alto, California, the US. Kodiak Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensiv......
$250